Focus on Equities that offer Growth,
Value and Strong Potential Return
Monday, October 20, 2014

AcelRx Pharmaceuticals, Inc.

In-Depth Research Report Available for ACRX

equity-static-img
Download Free Report Now

Company Profile ACRX

AcelRx Pharmaceuticals shares declined 0.29 percent to close at $10.29 a share Monday. The stock traded between $10.09 and $11.21 on volume of 576,976 shares traded. Analysts at Roth Capital have recently initiated coverage on the company with a “buy” rating and a price target of $22.00. Shares of AcelRx Pharmaceuticals have fallen approximately 9.0 percent year-to-date. Going forward ... (see research report)

News & Events ACRX